Winningham Rick E
Winningham Rick E, DIR, reported an open-market or private sale at Jazz Pharmaceuticals plc involving 2741.000000 shares for an estimated $662143.37. Reported holdings after the transaction were 9567.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 22, 2026
- Filing date
- May 27, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 12,308 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
JAZZ price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001302443-26-000008 Ordinary Shares
- Transaction date
- May 22, 2026 Filed May 27, 2026, 10:13 PM · 5d delay
- Shares
- 2,741 sh $241.57 per share
- Estimated value
- -$662k Computed from shares × price
- Holdings after
- 9,567 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017.
0 other transactions
0 recent txs